Froedtert to participate in study to treat COVID-19 with new drug remdesivir
-
3:01
Weekly Drought Monitor Reveals Southeast Wisconsin In The Best...
-
1:44
’The whole church is covered in water’: Greendale parish...
-
2:07
Biden admin highlights energy, housing tax credits during Madison...
-
2:22
Marquette channeling nervous energy at final practice before...
-
1:45
Milwaukee Common Council to vote on ordinance replacing food...
-
0:57
Brewers preview new dining options at 3rd Street Market Hall...
-
2:22
Parents upset after school district announces the end of a K-8...
-
2:39
VISIT Milwaukee preview: March 29-31
-
1:25
Take your pick of Easter goodies: CBS 58 stops by The Chocolate...
-
4:44
’In the Land of Saints and Sinners’ and ’Late Night with...
-
4:27
New location of veterans café helping vet community in Racine...
-
3:51
Milwaukee Art Museum Research Center
MILWAUKEE (CBS 58) -- We're learning more about the experimental drug being used to help treat severe COVID-19 patients.
Froedtert Hospital and the Medical College of Wisconsin (MCW) have enrolled in a study for the potential breakthrough drug.
It's called remdesivir.
"It is an antiviral medication that's been around for a number of years, and was used initially for trials with Ebola," said Dr. Mary Beth Graham, medical director of Infection Prevention & Control at Froedtert Hospital and associate chief of the Division of Infectious Disease at MCW.
According to the pharmaceutical company Gilead Sciences, patients with COVID-19 who received remdesivir recovered faster.
It will be given to ten patients at Froedtert under certain conditions. They have to be intubated and have renal and liver function.
"Very strict parameters that we have to follow on this trial from the drug company," said Dr. Graham, principal investigator on the study.
So how exactly does the drug work? It affects how cells grow.
"It essentially goes in and messes up the way the virus can make more of itself."
Remdesivir has yet to be approved by the FDA, but doctors say the data is positive.
"It's very, very, very encouraging," said Dr. Graham.
In the meantime, researchers continue to look into other ways to treat the virus, like from plasma donations.